Stock Screener App

무료 -

설치하다

4.635

5.82% 0.255

아이언우드 제약 (IRWD)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Ironwood Pharmaceuticals Inc 주식(IRWD)의 최신 뉴스

Price to earnings forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView

Ironwood Pharmaceuticals stock follows its own business case. IRWD trades on Nasdaq. - AD HOC NEWS

Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum - Yahoo Finance

Price to book forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView

IRWD Forecast — Price Target — Prediction for 2027 - TradingView

Gastroparesis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda - Barchart.com

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (BX:I76) - TradingView

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (SWB:I76) - TradingView

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (MUN:I76) - TradingView

I76 Forecast — Price Target — Prediction for 2027 - TradingView

5 Small Drug Stocks to Invest in Amid a Biotech Comeback - Yahoo Finance

Ironwood Pharmaceuticals (IRWD) Short Interest & Short Float | Updated Jun 2026 - MarketBeat

Ironwood Pharmaceuticals Inc (IRWD) Valuation: PE, PB & Fair Value Analysis - TradingKey

Ironwood Pharmaceuticals StockAnalyst snapshot and sector review at week’s end - AD HOC NEWS

IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill

Ironwood Pharmaceuticals (IRWD) adds 10M shares to 2019 equity incentive plan - Stock Titan

Ironwood Pharmaceuticals Inc (IRWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Ironwood Pharmaceuticals Inc - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Institutional Confidence - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Director Julie Mchugh Sells 21,571 Shares of Ironwood Pharmaceuticals Inc (IRWD) - GuruFocus

Ironwood Pharmaceuticals Inc (IRWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Ironwood (IRWD) director Jay Shepard receives 63,481-share restricted stock grant - Stock Titan

Ironwood (NASDAQ: IRWD) director awarded restricted stock that vests before next meeting - Stock Titan

Ironwood (IRWD) director Marla Kessler receives 63,481-share restricted stock grant - Stock Titan

Ironwood Pharmaceuticals (IRWD) director receives 63,481-share grant - Stock Titan

Ironwood Pharmaceuticals (IRWD) director granted 63,481 restricted shares in latest Form 4 - Stock Titan

Ironwood (NASDAQ: IRWD) director sells shares and receives new stock grant - Stock Titan

Director Catherine Moukheibir receives 63,481 Ironwood (IRWD) restricted shares - Stock Titan

[144] IRONWOOD PHARMACEUTICALS INC SEC Filing - Stock Titan

Ironwood Pharmaceuticals (IRWD) Jefferies London Healthcare Conference 2024 Summary - Quartr

Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026 - TradingView

Ironwood Pharmaceuticals (IRWD) retires $200M 2026 convertible notes in cash - Stock Titan

ZVRA Stock Price and Chart — NASDAQ:ZVRA - TradingView

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates - MSN

Ironwood Pharmaceuticals (IRWD) Tops Healthcare Sector with Stro - GuruFocus

These healthcare stocks are combining strong gains with reasonable prices (XLV:NYSEARCA) - Seeking Alpha

Can Linzess Continue Driving IRWD's Revenue Growth Through 2026? - Yahoo Finance

· SEC Filing - MLQ.ai

IRONWOOD PHARMACEUTICALS INC (IRWD) Stock Chart - ChartMill

IRWD: Apraglutide and LINZESS drive growth, with new trials, debt reduction, and market leadership ahead - TradingView

Ironwood Pharmaceuticals Signals Blockbuster Momentum in 2026 - The Globe and Mail

Ironwood Pharmaceuticals, Inc. (IRWD) Stock Price, News, Quote & History - Yahoo Finance

Ironwood Pharmaceuticals Expands Linzess Use and Drives Record Q1 2026 Revenue - asatunews.co.id

Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess? - Insider Monkey

Ironwood (IRWD) Q1 2026 Earnings Call Transcript - The Globe and Mail

Earnings Preview: IRWD to Report Financial Results Pre-market on May 07 - Moomoo

Ironwood Pharmaceuticals (IRWD) Proxy filing Summary - Quartr

Ironwood reiterates 2026 LINZESS guidance of $1.125B-$1.175B as STARS-2 initiation nears - MSN

IRWDIronwood Pharmaceuticals Inc Short Interest - Finviz

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2026 - BioSpace

Ironwood Pharmaceuticals to Present at Jefferies Global Healthcare Conference - geneonline.com

Ironwood Pharmaceuticals, Inc. (IRWD) stock price, news, quote and history - Yahoo Finance UK

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference - investor.ironwoodpharma.com

Ironwood Pharmaceuticals (IRWD) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

ALKS

$54.74

0.71%

RDY

$14.65

2.05%

ELAN

$24.65

1.89%

NBIX

$175.34

0.86%

VTRS

$17.00

1.16%

UTHR

$559.10

2.19%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개